Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Dementia

Five symptoms of dementia and early warning signs

One in four sufferers commonly go two years undiagnosed, one study claims

The Independent UK

This latest Alzheimer’s drug breakthrough is reason for hope – and further funding

Researchers are a step closer to unravelling the cruel mystery of the dementia that afflicts my wife and so many others

The Guardian - UK

Glasgow gran with dementia left with bleeding head wound after hospital fall as family hit out

Beatrice McNarey, 91, was recovering from surgery after breaking her hip when she fell, leaving her with a bleeding cut on her head. Her family has now raised concern about the level of care she is receiving.

Glasgow Live

From analysis to the latest developments in health,
read the most diverse news in one place.

The best charity Christmas cards for 2022 - and the good causes all money goes toward

We take a look at the best charity Christmas cards to send over the festive period, and explain exactly what good causes the money raised goes towards

Daily Mirror

The Guardian view on Alzheimer’s drugs: a working therapy would be a breakthrough

Editorial: The search for a cure for dementia continues, but scientific advance in treatment is a landmark moment

The Guardian - UK

I was told by doctors my memory loss was due to stress - but received a devastating diagnosis aged just 57

Mum-of-two Jude Thorp first went to the doctors after noticing changes to her cognitive abilities

Manchester Evening News

Experimental Alzheimer's drug shows promise – but there are many hurdles still to overcome

The first drug that can slow the rate of decline in Alzheimer’s patients has been found. The experimental drug, called lecanemab, is an antibody that targets the toxic clumps of amyloid protein associated with the mind-robbing disease. While these results are cause for celebration, there are still significant questions about…

The Conversation

Read news from The Economist, FT, and more,
with one subscription

Mum 'devastated' by young onset dementia diagnosis making most of life

Jude Thorp experienced bouts of memory loss, where she would often ask the same question multiple times, and she would forget significant conversations about plans

Wales Online

Alzheimer's breakthrough: Simple urine test can diagnose condiction years before symptoms

Drugs fail to halt the condition because they are administered too late

Wales Online

Five symptoms of dementia and early warning signs

One in four sufferers commonly go two years undiagnosed, one study claims

The Independent UK

Woman completes 50 challenges in 500 days for Alzheimer’s Research UK

Shelle Luscombe completed her first challenge in July 2021 – the month of her 50th birthday.

The Independent UK

Family concerned for missing man, 72, who suffers from dementia

Amjad was last seen leaving his Crumpsall home on Wednesday morning

Manchester Evening News

Emmerdale viewers point out problem with Bernice's health storyline

The character has been struggling with her health recently and fans have spotted a problem in how she is handling it.

Leeds Live

ITV Emmerdale viewers scream at TV as they uncover Bernice Blackstock's condition

The character was worried she was showing signs of dementia

Liverpool Echo

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

What is the difference between Alzheimer’s and dementia?

New drug proven to slow onset of degenerative brain disease as scientists hail ‘breakthrough’

Dublin Live

New Alzeimher’s drug could offer major breakthrough in treating disease

Scientists are optimistic about Lecanemab, which has slowed down cognitive decline in clinical trials

Manchester Evening News

Drug proven to slow decline in Alzheimer patients

Lecanemab, a newly developed drug, has showed promising results in clinical trials among Alzheimer patients

The New Daily

‘Momentous breakthrough’: New Alzheimer’s drug lives up to bold claims, with caveats

Data supports claims that a new drug reduced cognitive and functional decline in Alzheimer's patients by 27 per cent in a clinical trial.

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK

NHS ‘nowhere near ready’ to deliver new Alzheimer’s drug, doctors say

Patients unlikely to receive lecanemab before 2026 and health service does not yet have necessary infrastructure

The Guardian - UK

It’s just a first step, but this new Alzheimer’s drug could be a huge breakthrough

Recent lecanemab trials are reason for hope, although health services may struggle to deliver treatments, says dementia researcher Jonathan Schott

Evening Standard

Lecanemab: new Alzheimer’s drug hailed as ‘beginning of the end’ for disease

A ground-breaking drug has been found to slow cognitive decline in people with Alzheimer’s - with experts hailing it a breakthrough that “can meaningfully change the course of the disease”.

Daily Mirror

Breakthrough Alzheimer's drug hailed as 'beginning of the end' for treating disease

Lecanemab was found to have reduced memory decline by targeting and clearing amyloid, which is one of the proteins that build up in the brains of people with the disease

Wales Online

Simple urine test could be used to diagnose early-stage Alzheimer’s disease

The early stage of the disease occurs before the irreversible dementia stage and is the golden window for intervention and treatment

Wales Online

New Alzheimer’s drug hailed as 'beginning of the end' in quest for treatment

Clinical results suggest that the disease progression can by slowed by 27%

The Independent UK

New Alzheimer’s drug hailed as ‘beginning of the end’ in search for treatment

Lecanemab was found to slow decline in patients’ memory and thinking.

1 … 93 94 95 96

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Alzheimer Research UK

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.